A recent report has proposed that CIP associated with loss of Nav1.7 causes analgesia via an increase in expression of the enkephalin precursor gene PENK. CIP in humans was shown to be substantially reversed by the opioid antagonist naloxone supporting this hypothesis [20]. The gene discussed is PENK; the disease is hereditary sensory and autonomic neuropathy.